Skip to content
lifestyle.briefmobile.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Nanobiotix S.A.
NANOBIOTIX Announces Presentation of First Data from a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer
May 5, 2026
NANOBIOTIX Statement Regarding Recent Media Speculation
May 4, 2026
Voting Rights and Shares Capital of the Company
May 2, 2026
NANOBIOTIX to Participate in Investor Conferences in March
April 30, 2026
NANOBIOTIX Provides Business Update and Reports Full Year 2025 Financial Results
April 1, 2026
←
Previous Page
1
2
3